Over the past decade cardiovascular surgery has evolved due to the growing knowledge and technology surrounding the industry. Surgeons are continuously being equipped with performance enhanced, technologically improved medical devices that continue to ease the process of operating. Technology has come and gone, but all surrounding the same idea of open-heart surgery. Open heart surgery is defined as surgery in which the heart is exposed, and the blood made to bypass it.
The procedure begins with the cardiac surgeon dividing your sternum to visualize your heart and surrounding structures. After the surgery, the surgeon must repair your sternum by aligning the bone in the proper place. Usually, a strong wire is used to hold the bones together while healing takes place. The healing process alone from a procedure of this sort is a very long road that can vary patient to patient considering their health, age and other characteristics prior to the surgery. Not only is the healing process long, but patients are left with a long scarring incision on their chest post procedure.
In the past 40 years advancements in imaging and technology has led to a new, different approach to cardiovascular surgery. Minimally invasive surgery is a relatively new method of surgery since the 1980’s that could possibly suppress the detrimental recovery and scarring that comes with open heart surgeries. Minimally invasive surgery does not need as large of a dose of pain relievers because the incision during surgery is much smaller. The procedure involves minimizing surgical incisions to reduce trauma to the body. This type of surgery is usually performed using thin-needles and an endoscope to visually guide the surgery.
With smaller incisions, in comparison to open heart procedures, the hospital stay is typically shorter, there is less scarring, the size of the incision enables one to heal faster, as well as the sternum is not opened to operate. With these pros to the new findings and advancement in minimally invasive surgery, the market for this procedure is growing. Over the past three years there has been a 15% CAGR of minimally invasive heart valve replacements.
This number is expected to continue to grow and the global market size is predicted to reach 40.52 billion USD by 2025. With an inclination to get procedures done with a minimal invasive method, new medical devices will grow in demand. The future of minimal invasive surgery leads surgeons and patients towards a new, safer and smaller future of cardiovascular procedures.
Surge Cardiovascular is an ISO 13485 certified medical device manufacturer that proactively addresses the unique needs of progressive and demanding cardiac care professionals. Our strategy is laser focused on responding to innovative product development requirements, timely device launches, and a steadfast commitment to quality.
As a veteran owned company our products are manufactured with intricate precision, under the strictest process controls, in the U.S.A.
PRNewsWire.2018, July 18).GlobalMinimallyInvasiveSurgicalSystemsMarkettoReach40.52 Billionby2025,ReportsBISResearch.Retrievedfrom- https://www.prnewswire.com/news-releases/global-minimally-invasive-surgical-systems-market-to-reach-40-52-billion-by-2025-reports-bis-research-888195869.html